Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

You are 80 per cent likely to be diagnosed with a type of cervical cancer called squamous cell carcinoma (SCC) if your mum, sister or daughter has had cervical cancer, according to a 2008 study in ...

Also Read: Cervical cancer could be hiding in plain sight ... and other sources to categorise lung cancer cases into four subtypes: adenocarcinoma, squamous cell carcinoma, and small—and large-cell ...

Almost all cases are caused by human papillomavirus (HPV) infection, with approximately 80% classified as squamous cell carcinoma (SCC); the remainder are largely adenocarcinomas. Cervical cancer ...

Approximately 90% are squamous cell carcinomas, and the remaining 10% are adenocarcinomas. This cancer originates ... of small cell neuroendocrine cervical carcinoma revealed the tumor ...

Patients with recurrent or metastatic cervical cancer with squamous cell, adenocarcinoma, or adenosquamous histology, and disease progression during or after treatment with chemotherapy doublet ...

PYX-201, an antibody-drug conjugate (ADC) with a microtubule inhibitor (optimized auristatin) payload that uniquely targets ...

This type of cancer starts in the squamous cells. Squamous cells line the cervix, and they can be damaged by HPV infection. Squamous cell carcinoma is the most common type of cervical cancer. The ...

HPV is a common virus spread via sexual contact, which can cause cervical and throat cancer. Most infections clear on their own, however high-risk types like HPV-16 are connected with severe cases.